3种常用改善肝功能药物治疗药物性肝损伤的效果比较

王准; 龚天斌

doi:10.3969/j.issn.1001-5256.2016.04.033

3种常用改善肝功能药物治疗药物性肝损伤的效果比较

DOI: 10.3969/j.issn.1001-5256.2016.04.033

王准,
龚天斌

应城市人民医院

详细信息

中图分类号: R575
计量
- 文章访问数: 333
- HTML全文浏览量: 34
- PDF下载量: 170
- 被引次数: 0
出版历程
- 出版日期: 2016-04-20

Efficacy of three liver- protecting drugs commonly used in treatment of drug- induced liver injury: a comparative analysis

Yingcheng People′s Hospital

摘要

摘要:
目的对比3种常用改善肝功能药物治疗药物性肝损伤的效果。方法回顾性分析2012年11月-2015年4月于应城市人民医院治疗的90例药物性肝损伤患者的临床资料,根据治疗用药的不同,分为A、B、C 3组,每组30例。其中A组采用还原型谷胱甘肽治疗,B组采用多烯磷脂酰胆碱注射液治疗,C组患者采用硫普罗宁注射液治疗。对比3组患者治疗效果、药物成本以及不良反应发生率。计量资料多组间比采用方差分析,进一步两两比较采用LSD-t检验;计数资料多组间比较采用χ2检验。结果A组总有效率为90.0%,明显高于B组（73.3%）和C组（76.7%）,差异均有统计学意义（χ2值分别为2.78、3.75,P值均<0.05）。B组药物成本为（316.12±4.05）元,明显高于A组（235.13±2.90）元和C组（135.21±7.62）元,差异均有统计学意义（P值均<0.01）。3组不良反应发生率比较差异无统计学意义（p>0.05）。结论在药物性肝损伤的临床治疗中,还原型谷胱甘肽较多烯磷脂酰胆碱、硫普罗宁所获效果更为显著,同时成...
- 肝疾病 /
- 药物疗法 /
- 对比研究
Abstract:
Objective To compare the efficacy of three liver- protecting drugs commonly used in the treatment of drug- induced liver injury. Methods The clinical data of 90 patients with drug- induced liver injury who were treated in Yingcheng People's Hospital from November 2012 to April 2015 were analyzed retrospectively,and according to the drugs administered,they were divided into groups A,B,and C,with 30 patients in each group. The patients in groups A,B,and C were treated with reduced glutathione,polyene phosphatidylcholine injection,and tiopronin injection,respectively. The efficacy,drug cost,and incidence of adverse events were compared between the three groups. An analysis of variance was used for comparison of continuous data between multiple groups,and the LSD t- test was used for comparison of continuous data between any two groups; the chi- square test was used for comparison of categorical data between multiple groups.Results Group A had a significantly higher overall response rate than groups B and C( 90. 0% vs 73. 3% /76. 7%,χ~2= 2. 78 and 3. 75,both P < 0. 05). Group B had a significantly higher drug cost than groups A and C( 316. 12 ± 4. 05 RMB vs 235. 13 ± 2. 90 and 135. 21 ±7. 62 RMB,both P < 0. 01). The incidence of adverse events showed no significant differences between the three groups( P > 0. 05). Conclusion In the clinical treatment of drug- induced liver injury,reduced glutathione has better efficacy compared with polyene phosphatidylcholine and tiopronin,as well as a reasonable cost. Therefore,this drug is preferred in the treatment of this disease.
- liver diseases /
- drug therapy /
- comparative study

HTML全文

参考文献(15)

[1]CHEN PR,TAN SY.Influence of a combination of various liverprotecting drugs on incidence of drug-induced liver injury[J].Chin J Tuberc Respir Dis,2014,37(1):58-59.(in Chinese)陈品儒,谭守勇.联合不同种类保肝药物对药物性肝损伤发生率的影响[J].中华结核和呼吸杂志,2014,37(1):58-59.

[2]TIAN YM,DOU LP,YAO S,et al.Protective effect of ademetionine1,4-butanedisulfonate on liver injury caused by chemotherapeutic agents[J].J Exp Hematol,2013,21(5):1305-1308.(in Chinese)田亚敏,窦丽萍,姚盛,等.S-腺苷蛋氨酸对化疗药物性肝损伤防治疗效的观察[J].中国实验血液学杂志,2013,21(5):1305-1308.

[3]HAWASA UW,SOLIMAN GM,EL-KASSEM LT,et al.A new flavonoid C-glycoside from solanum elaeagnifolium with hepatoprotective and curative activities against paracetamol-induced liver injury in mice[J].Z Naturforsch C,2013,68(1-2):19-28.

[4]DU H,TANG Z,GE LH,et al.Cost-effectiveness analysis of 3therapeutic schemes in treating antituberculosis drug-induced hepatotoxicity in HIV/TB patients[J].J Clin Pulm Med,2012,17(8):1430-1432.(in Chinese)杜红,汤卓,葛利辉,等.3种用药方案治疗HIV/TB患者抗结核药物性肝损伤成本-效果分析[J].临床肺科杂志,2012,17(8):1430-1432.

[5]WU S,YUE Y,TIAN H,et al.Carthamus red from carthamus tinctorius L.exerts antioxidant and hepatoprotective effect against CCl(4)-induced liver damage in rats via the Nrf2 pathway[J].JEthnopharmacol,2013,148(2):570-578.

[6]HUANG GY,WANG YM.Pharmacoeconomic profiles of four hepatoprotective drugs used for the treatment of drug-induced liver injury[J].Chin J Hepatol,2014,22(10):763-768.(in Chinese)黄广宇,王宇明.四种常用保肝药治疗药物性肝损伤的药物经济学分析[J].中华肝脏病杂志,2014,22(10):763-768.

[7]LAN D,GAN TQ,WANG L,et al.Value of prophylactic liver-protecting treatment for drug-induced liver injury caused by breast cancer chemotherapy[J].J Guangxi Med Univ,2015,32(2):281-283.(in Chinese)蓝东,甘廷庆,王莉,等.预防性保肝对乳腺癌化疗所致药物性肝损伤的应用价值[J].广西医科大学学报,2015,32(2):281-283.

[8]DONG Y,HUANG J,LIN X,et al.Hepatoprotective effects of yulangsan polysaccharide against isoniazid and rifampicin-induced liver injury in mice[J].J Ethnopharmacol,2014,152(1):201-206.

[9]ALI H,KABIR N,MUHAMMAD A,et al.Hautriwaic acid as one of the hepatoprotective constituent of dodonaea viscosa[J].Phytomedicine,2014,21(2):131-140.

[10]LAI RT,WANG H,GUI HL,et al.Clinical and pathological features in 138 cases of drug-induced liver injury[J].Chin J Hepatol,2012,20(3):185-189.(in Chinese)赖荣陶,王晖,桂红莲,等.138例药物性肝损伤患者的临床特征及肝脏组织学改变[J].中华肝脏病杂志,2012,20(3):185-189.

[11]ARCHANA PR,VEENA G,SIVARAJ N,et al.Andrographis paniculata(burm.f.)wall.ex nees(kalmegh),a traditional hepatoprotective drug from India[J].Genet Resour Crop Evol,2013,60(3):1181-1189.

[12]JIN G,LANLAN Z,LI C,et al.Pregnancy outcome following loop electrosurgical excision procedure(LEEP)a systematic review and meta-analysis[J].Arch Gynecol Obstet,2014,289(1):85-99.

[13]TANG LN,LIN F,SHEN Z,et al.Magnesium isoglycyrrhizinate used in the treatment of chemotherapeutic drugs-induced acute liver dysfunction:a phaseⅢclinical trial[J].Tumor,2012,32(9):738-743.(in Chinese)汤丽娜,林峰,沈赞,等.异甘草酸镁治疗抗肿瘤药物引起的急性药物性肝损伤的Ⅲ期临床试验[J].肿瘤,2012,32(9):738-743.

[14]HUSSAIN L,IKRAM J,REHMAN K,et al.Hepatoprotective effects of Malva sylvestris L.against paracetamol-induced hepatotoxicity[J].Türksh J Biol,2014,38(3):396-402.

[15]YANG XY,LI Y,LI ZM,et al.Protective effects of liver protective drugs on liver injury induced by anti-tuberculosis drugs[J].The JPract Med,2015,13:2194-2196.(in Chinese)杨雪迎,李艳,李哲明,等.护肝药物预防抗结核药物所致肝损伤的作用[J].实用医学杂志,2015,13:2194-2196.

施引文献

资源附件(0)

访问统计